Sarath Chandar serves as the Vice President of Strategic Development, Technology & Licensing at SPI Pharma, where he leverages his extensive expertise in drug development and business strategy to drive innovation and growth within the pharmaceutical industry. With a strong track record in corporate strategy...
Sarath Chandar serves as the Vice President of Strategic Development, Technology & Licensing at SPI Pharma, where he leverages his extensive expertise in drug development and business strategy to drive innovation and growth within the pharmaceutical industry. With a strong track record in corporate strategy and business development, Sarath is a creative visionary who excels in identifying and cultivating strategic partnerships and joint ventures that enhance SPI Pharma's competitive edge. His role involves overseeing the excipients and drug delivery systems SBU, where he focuses on optimizing product offerings and expanding market reach.
Under Sarath's leadership, key projects have included the development of novel excipients that improve drug solubility and bioavailability, addressing critical challenges in formulation science. His inquisitive nature and ability to rapidly assimilate complex information allow him to navigate the intricacies of drug development, ensuring that SPI Pharma remains at the forefront of innovation. Sarath is particularly adept at out-licensing initiatives, where he identifies opportunities for collaboration with other industry leaders, facilitating the transfer of technology and expertise that accelerates the development of new therapeutics.
In addition to his strategic oversight, Sarath is committed to fostering a culture of creativity and collaboration within his team, encouraging innovative thinking that drives successful outcomes. His blend of analytical skills and business acumen positions him as a key player in shaping the future of SPI Pharma, as he continues to explore new avenues for growth and advancement in the ever-evolving pharmaceutical landscape.
